Related Experiment Video
Updated: Jun 14, 2025
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
3.7K
Satisfaction with videoconferencing support for levodopa-carbidopa intestinal gel: An observational study
Tanya Gurevich1,2, Andrew Evans3, Sharon Hassin-Baer2,4
1Movement Disorders Unit, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Digital Health
|September 3, 2024
Summary
Video-assisted telenursing for Levodopa-carbidopa intestinal gel (LCIG) support programs shows high satisfaction. This approach may offer a convenient communication method and reduce caregiver burden for Parkinson's disease patients.
Area of Science:
- Neurology
- Gerontology
- Health Services Research
Background:
- Levodopa-carbidopa intestinal gel (LCIG) is a continuous infusion therapy for Parkinson's disease.
- Effective patient education and follow-up are crucial for LCIG therapy management.
- Video-assisted telenursing is an emerging modality for supporting LCIG patients.
Purpose of the Study:
- To evaluate the impact of videoconferencing on patient satisfaction with LCIG support programs.
- To compare satisfaction levels between video and audio-only support arms.
Main Methods:
- The FACILITATE CARE study was a 12-week observational trial with two arms: video and audio-only.
- Participants were patients aged 18-85 years using LCIG and owning a videoconferencing device (for the video arm).
- Satisfaction was measured using a visual analog scale (1-10).
Main Results:
- Both video and audio arms reported high satisfaction (scores 8-10) with LCIG support.
- The video arm showed a greater reduction in caregiver strain compared to the audio arm.
- LCIG support personnel travel time was significantly lower in the video arm.
Conclusions:
- LCIG support programs, whether video or audio-based, are associated with high satisfaction among patients, caregivers, and physicians.
- Video-assisted telenursing presents a viable and convenient communication channel for LCIG support.
- This approach has the potential to decrease caregiver burden and improve support accessibility.
Related Concept Videos
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
704
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
704
01:18Drug Delivery: Enteral Route
395
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
395
01:24Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
952
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
952
01:26Cholinergic Antagonists: Therapeutic Uses
730
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
730
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K